AKT1 and cancer: Research has found that ginsenoside CK can effectively inhibit the expression of AKT/mTOR/p70S6K1 proteins in cancer cells, block the PI3K/AKT/mTOR signaling pathway, and reduce the expression of MMP2 and MMP9 proteases.